Skip to main content
Clinical Trials/JPRN-UMIN000001658
JPRN-UMIN000001658
Completed
Phase 2

A randomized controlled Phase II study comparing TS-1 alone with CDDP+TS-1 as postoperative adjuvant chemotherapy in non-small-cell-lung-cancer ; translational research of the chemotherapy effect prediction factor - WJOG4107

West Japan Oncology Group0 sites200 target enrollmentJanuary 26, 2009

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
on Small Cell Lung Cancer
Sponsor
West Japan Oncology Group
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 26, 2009
End Date
August 1, 2015
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) clinically significant drug allergy 2\) Under treatment with flucytosine, phenytoin, Warfarin Potassium, other trial drugs. 3\) The infection which needs the medical treatment by antibiotics, and other serious complications 4\) The case which has diarrhea continuously 5\) The case which has clear interstitial pneumonia or a clear fibroid lung with a chest simple X ray 6\) The case which has malignant tumors other than the lung cancer 7\) The case which has the past of a malignant tumor 8\) Not suitable for participating in the study for any other reason

Outcomes

Primary Outcomes

Not specified

Similar Trials